A caspase-9 variant missing the catalytic site is an endogenous inhibitor of apoptosis.
about
Mechanisms of benzene-induced hematotoxicity and leukemogenicity: cDNA microarray analyses using mouse bone marrow tissue.MECHANISMS IN ENDOCRINOLOGY: Alternative splicing: the new frontier in diabetes researchSplicing Regulation: A Molecular Device to Enhance Cancer Cell AdaptationPhysical and functional interaction between Hck tyrosine kinase and guanine nucleotide exchange factor C3G results in apoptosis, which is independent of C3G catalytic domainCharacterization of a novel isoform of caspase-9 that inhibits apoptosisModulation of apoptosis by procaspase-2 short isoform: selective inhibition of chromatin condensation, apoptotic body formation and phosphatidylserine externalization.Caspase-9: structure, mechanisms and clinical applicationPostmitochondrial regulation of apoptosis during heart failureA comprehensive characterization of the caspase gene family in insects from the order Lepidoptera.A short caspase-3 isoform inhibits chemotherapy-induced apoptosis by blocking apoptosome assembly.Alternatively spliced caspase-6B isoform inhibits the activation of caspase-6A.Apoptosis and its clinical impact.hnRNP L regulates the tumorigenic capacity of lung cancer xenografts in mice via caspase-9 pre-mRNA processingLiving or dying by RNA processing: caspase expression in NSCLC.Effect of hyperthermia in combination with TRAIL on the JNK-Bim signal transduction pathway and growth of xenograft tumors.Tumor necrosis factor-related apoptosis-inducing ligand induces caspase-dependent interleukin-8 expression and apoptosis in human astroglioma cells.Caspase-1 and IL-1β processing in a teleost fishAlternative splicing of caspase 9 is modulated by the phosphoinositide 3-kinase/Akt pathway via phosphorylation of SRp30a.Molecular basis for the action of a dietary flavonoid revealed by the comprehensive identification of apigenin human targets.Intra-articular injection of recombinant TRAIL induces synovial apoptosis and reduces inflammation in a rabbit knee model of arthritisSRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cellsDifferentially regulated splice variants and systems biology analysis of Kaposi's sarcoma-associated herpesvirus-infected lymphatic endothelial cells.Caspase-9 and APAF-1 form an active holoenzyme.Alternative RNA splicing and cancerAdult neuron survival strategies--slamming on the brakes.Mammalian initiator apoptotic caspases.Bcl-x pre-mRNA splicing regulates brain injury after neonatal hypoxia-ischemia.Detection of alternative splicing during epithelial-mesenchymal transition.hnRNP U enhances caspase-9 splicing and is modulated by AKT-dependent phosphorylation of hnRNP LEvaluation of Caspase-9b and PP2Acα2 as potential biomarkers for chronic lymphocytic leukemia.Caspase-9b Interacts Directly with cIAP1 to Drive Agonist-Independent Activation of NF-κB and Lung TumorigenesisThe enigmatic roles of caspases in tumor developmentDecreased Expression of SRSF2 Splicing Factor Inhibits Apoptotic Pathways in Renal Cancer.Cellular mechanisms controlling caspase activation and function.A dominant-negative isoform lacking exons 11 and 12 of the human hypoxia-inducible factor-1alpha geneAlternative splicing: the pledge, the turn, and the prestige : The key role of alternative splicing in human biological systems.Effects of paclitaxel on permanent head and neck squamous cell carcinoma cell lines and identification of anti-apoptotic caspase 9b.Survivin silencing and TRAIL expression using oncolytic adenovirus increase anti-tumorigenic activity in gemcitabine-resistant pancreatic cancer cells.Alternative splicing and cell survival: from tissue homeostasis to disease.Preferential cytotoxicity of the type I ribosome inactivating protein alpha-momorcharin on human nasopharyngeal carcinoma cells under normoxia and hypoxia.
P2860
Q24815877-52492AD3-3BA0-4C81-A225-D5FEF82194DDQ26775510-6EC014A5-CC79-4B39-907A-FF11DCFD19DEQ26798148-BFE5EB5C-3CB6-4B9C-BAA1-544F78D43DCDQ28208742-C585DB94-2638-4828-BE9D-F1BC547A1C2FQ28579902-58E89547-683B-4248-BDEF-376AF197F68FQ33181924-76FE1E6C-8333-4D68-AD9A-DFB9B215DA7FQ33618946-89296264-D29A-4D64-9C7A-4A40FB3794C4Q33679417-B2192DF2-7BF0-446E-BD40-2E48D0D2EC66Q33955906-C24CF2CA-9506-45A4-A2B0-54104C86454CQ34117158-53652E0F-F679-40F1-BDF0-7A77C6670C94Q34186347-BC4FCFD3-F0CD-4FB4-9197-144288A8439FQ34214558-6FB42C59-298B-4808-BBC8-B5FC80519B26Q34245430-EE663846-9E9C-4DA4-AAB1-1B670C1CD56AQ34245513-02338E28-3043-4382-AB42-2D3E0475CF4BQ34257806-2A4A8D54-EB97-4483-9F85-61AABADE2A13Q34272896-C0376799-79F2-481E-8012-A083B0739CF5Q34505406-BB69BFE8-2CEB-45B0-9B92-B909A718BC71Q34685905-7D5E2E1D-1427-4982-BAB5-C5BFF3ADCAE1Q34734385-9F814751-B464-4A9C-B3C8-DDC1FE307829Q34896505-6C5782A8-E5CF-4D91-8E48-0FF2A060159AQ35118687-E75EFD0A-C8E4-48E1-8A25-A6EDC630DBC1Q35198402-168269BA-D31E-4165-BF9C-0A8F7AB8ADD9Q35210359-58C9FBE4-B869-4FE1-B5F3-AECC23403670Q35589667-FE7A3066-6C8A-4AE6-A45D-C750B81E96D6Q35868063-BCEFA257-F4FF-485E-B9F7-0BE2675ADDD7Q36302900-2ABF6D73-3F0D-4925-9F1C-C33522809C9DQ36351445-4A073FAC-0DA9-4291-A199-91AE7B5A9C97Q36407860-3FA7E10B-5DF9-4B96-B0D9-9C8D064CD7E2Q36708640-90C2344D-9CB6-4A2C-BBB8-B2248325BE0AQ36871720-A61F0FE1-50FC-41A6-AB7A-B37DE0EB61ACQ36921618-2E3E656B-B311-4EAA-9A9C-1B963B91B306Q37342739-0803F591-4882-430F-BE3A-98B64167B274Q37377166-519C1FFB-5D8D-4F78-8FB7-9A715B5EC6ABQ38111614-339304BD-EBD7-40ED-B1BF-24DC2FB00131Q38292308-D9D5B146-7D55-457F-9C3F-E8D2FC7D4087Q38735423-8F1FA676-EE5F-402B-8C88-D67CB7368BA6Q38781385-03462C58-5A70-46DD-8F23-DAF1CB13144CQ38811077-D20529E1-3742-4F34-ADD7-76B3A933F377Q38968877-C656C35F-73AD-4BE7-B975-6A584B5D5B6EQ39014629-09D8B7B7-2C98-4EA0-8C07-DEE5E01D90F7
P2860
A caspase-9 variant missing the catalytic site is an endogenous inhibitor of apoptosis.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
A caspase-9 variant missing the catalytic site is an endogenous inhibitor of apoptosis.
@en
type
label
A caspase-9 variant missing the catalytic site is an endogenous inhibitor of apoptosis.
@en
prefLabel
A caspase-9 variant missing the catalytic site is an endogenous inhibitor of apoptosis.
@en
P2860
P356
P1476
A caspase-9 variant missing the catalytic site is an endogenous inhibitor of apoptosis.
@en
P2093
P2860
P304
P356
10.1074/JBC.274.4.2072
P407
P577
1999-01-01T00:00:00Z